• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立人群免疫模型以支持消灭活脊髓灰质炎病毒传播的努力。

Modeling population immunity to support efforts to end the transmission of live polioviruses.

机构信息

Kid Risk, Inc., 10524 Moss Park Rd., Ste. 204-364, Orlando, FL 32832, USA.

出版信息

Risk Anal. 2013 Apr;33(4):647-63. doi: 10.1111/j.1539-6924.2012.01891.x. Epub 2012 Sep 17.

DOI:10.1111/j.1539-6924.2012.01891.x
PMID:22985171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7896539/
Abstract

Eradication of wild poliovirus (WPV) types 1 and 3, prevention and cessation of circulating vaccine-derived polioviruses, and achievement and maintenance of a world free of paralytic polio cases requires active risk management by focusing on population immunity and coordinated cessation of oral poliovirus vaccine (OPV). We suggest the need for a complementary and different conceptual approach to achieve eradication compared to the current case-based approach using surveillance for acute flaccid paralysis (AFP) to identify symptomatic poliovirus infections. Specifically, we describe a modeling approach to characterize overall population immunity to poliovirus transmission. The approach deals with the realities that exposure to live polioviruses (e.g., WPV, OPV) and/or vaccination with inactivated poliovirus vaccine provides protection from paralytic polio (i.e., disease), but does not eliminate the potential for reinfection or asymptomatic participation in poliovirus transmission, which may increase with time because of waning immunity. The AFP surveillance system provides evidence of symptomatic poliovirus infections detected, which indicate immunity gaps after outbreaks occur, and this system represents an appropriate focus for controlling disease outbreaks. We describe a conceptual dynamic model to characterize population immunity to poliovirus transmission that helps identify risks created by immunity gaps before outbreaks occur, which provides an opportunity for national and global policymakers to manage the risk of poliovirus and prevent outbreaks before they occur. We suggest that dynamically modeling risk represents an essential tool as the number of cases approaches zero.

摘要

消灭野生脊灰病毒(WPV)1 型和 3 型、预防和阻断循环疫苗衍生脊灰病毒、实现并维持无麻痹性脊灰病例的世界,需要通过关注人群免疫力和协调停止口服脊灰疫苗(OPV)来积极进行风险管理。我们建议,与目前使用急性弛缓性麻痹(AFP)监测来发现有症状脊灰病毒感染的基于病例的方法相比,需要采用补充的、不同的概念方法来实现消灭脊灰病毒。具体而言,我们描述了一种建模方法来描述人群对脊灰病毒传播的总体免疫力。该方法应对以下现实情况:接触活脊灰病毒(例如 WPV、OPV)和/或接种脊灰灭活疫苗可提供对麻痹性脊灰(即疾病)的保护,但不能消除再次感染或无症状参与脊灰病毒传播的可能性,而这种可能性会随着时间的推移因为免疫力下降而增加。AFP 监测系统提供了已检测到的有症状脊灰病毒感染的证据,这些感染表明在暴发发生后存在免疫空白,该系统代表了控制疾病暴发的适当重点。我们描述了一种概念性动态模型,用于描述人群对脊灰病毒传播的免疫力,有助于在暴发发生之前识别由免疫空白造成的风险,为国家和全球政策制定者提供了管理脊灰病毒风险和预防暴发的机会。我们建议,随着病例数量接近零,动态建模风险是一项重要工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba8/7896539/ec02e37c8f18/nihms-1670162-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba8/7896539/5dcf81a88dfd/nihms-1670162-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba8/7896539/ec02e37c8f18/nihms-1670162-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba8/7896539/5dcf81a88dfd/nihms-1670162-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ba8/7896539/ec02e37c8f18/nihms-1670162-f0002.jpg

相似文献

1
Modeling population immunity to support efforts to end the transmission of live polioviruses.建立人群免疫模型以支持消灭活脊髓灰质炎病毒传播的努力。
Risk Anal. 2013 Apr;33(4):647-63. doi: 10.1111/j.1539-6924.2012.01891.x. Epub 2012 Sep 17.
2
Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.评估停用口服脊髓灰质炎疫苗后消灭脊灰的稳定性。
PLoS Biol. 2018 Apr 27;16(4):e2002468. doi: 10.1371/journal.pbio.2002468. eCollection 2018 Apr.
3
Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses.管理人群免疫力,以降低或消除脊髓灰质炎病毒输入后传播的风险。
Vaccine. 2015 Mar 24;33(13):1568-77. doi: 10.1016/j.vaccine.2015.02.013. Epub 2015 Feb 18.
4
Intestinal mucosal immunity is unimportant for polio eradication: the failure of oral polio vaccination.肠道黏膜免疫对消灭脊髓灰质炎不重要:口服脊髓灰质炎疫苗的失败。
Infect Dis (Lond). 2024 Aug;56(8):669-677. doi: 10.1080/23744235.2024.2367742. Epub 2024 Jun 18.
5
Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India.建立模型以提高人群免疫力并预防印度北部 2 个高危地区的脊髓灰质炎病毒传播。
J Infect Dis. 2014 Nov 1;210 Suppl 1:S398-411. doi: 10.1093/infdis/jit844.
6
Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.在脊髓灰质炎病毒传播看似中断后对未检测到的活病毒传播进行建模:对监测和疫苗接种的影响
BMC Infect Dis. 2015 Feb 18;15:66. doi: 10.1186/s12879-015-0791-5.
7
Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.2013年输入以色列的1型野生脊髓灰质炎病毒的管理建模选项。
J Infect Dis. 2015 Jun 1;211(11):1800-12. doi: 10.1093/infdis/jiu674. Epub 2014 Dec 10.
8
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission.口服脊髓灰质炎疫苗配方选择对脊髓灰质炎病毒传播的血清型特异性群体免疫的差异影响。
BMC Infect Dis. 2015 Sep 17;15:376. doi: 10.1186/s12879-015-1116-4.
9
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use.全球协调停用二价口服脊髓灰质炎疫苗的规划:非同步停用和未经授权使用口服脊髓灰质炎疫苗的风险。
BMC Infect Dis. 2018 Apr 10;18(1):165. doi: 10.1186/s12879-018-3074-0.
10
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and Afghanistan.建模后明显中断传播的未检测到的活脊髓灰质炎病毒循环:巴基斯坦和阿富汗。
Risk Anal. 2019 Feb;39(2):402-413. doi: 10.1111/risa.13214. Epub 2018 Oct 8.

引用本文的文献

1
Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV).在全球协调停止使用二价口服脊髓灰质炎疫苗(bOPV)之前提高人群免疫力。
Pathogens. 2024 Sep 17;13(9):804. doi: 10.3390/pathogens13090804.
2
Estimation of the poliovirus type 2 immunity gap in South Africa.南非 2 型脊灰病毒免疫缺口的估计。
Vaccine. 2024 Oct 3;42(23):126062. doi: 10.1016/j.vaccine.2024.06.029. Epub 2024 Jul 4.
3
Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.不同脊髓灰质炎疫苗选择在应对美国和其他仅在常规免疫中使用灭活脊髓灰质炎疫苗(IPV)的国家的脊髓灰质炎疫情中的权衡。
Vaccine. 2024 Feb 6;42(4):819-827. doi: 10.1016/j.vaccine.2023.12.081. Epub 2024 Jan 12.
4
Modeling Poliovirus Transmission and Responses in New York State.在纽约州建立脊髓灰质炎病毒传播和反应模型。
J Infect Dis. 2024 Apr 12;229(4):1097-1106. doi: 10.1093/infdis/jiad355.
5
Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation.在停止口服脊髓灰质炎疫苗(OPV)接种后,国家免疫规划中重新启动OPV相关选项的复杂性。
Gates Open Res. 2023 Apr 17;7:55. doi: 10.12688/gatesopenres.14511.1. eCollection 2023.
6
Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation.回顾用于管理全球 2 型口服脊髓灰质炎疫苗(OPV2)停用的暴发应对策略的前瞻性建模。
Front Public Health. 2023 Mar 24;11:1098419. doi: 10.3389/fpubh.2023.1098419. eCollection 2023.
7
Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036.消灭脊髓灰质炎终局疫苗选择的卫生经济学分析:2022-2036 年。
Expert Rev Vaccines. 2022 Nov;21(11):1667-1674. doi: 10.1080/14760584.2022.2128108. Epub 2022 Oct 5.
8
Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan.模拟在巴基斯坦和阿富汗结束脊髓灰质炎病毒传播的情景。
Risk Anal. 2023 Apr;43(4):660-676. doi: 10.1111/risa.13983. Epub 2022 Jun 23.
9
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.全球口服脊髓灰质炎疫苗库存管理作为全球停用口服脊髓灰质炎病毒 2 型疫苗后应对 2 型脊髓灰质炎病毒暴发的一项重要的准备和应对机制。
Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A70-A78. doi: 10.1016/j.vaccine.2022.02.058. Epub 2022 Mar 10.
10
Using integrated modeling to support the global eradication of vaccine-preventable diseases.运用综合建模支持全球消除疫苗可预防疾病。
Syst Dyn Rev. 2018 Jun;34(1-2):78-120. doi: 10.1002/sdr.1589.

本文引用的文献

1
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.脊髓灰质炎病毒免疫和传播的回顾与评估:知识空白的综合分析与研究需求的确定。
Risk Anal. 2013 Apr;33(4):606-46. doi: 10.1111/risa.12031. Epub 2013 Mar 28.
2
Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.描述脊灰病毒的传播和演变:野病毒和疫苗相关脊灰病毒建模经验的启示。
Risk Anal. 2013 Apr;33(4):703-49. doi: 10.1111/risa.12044. Epub 2013 Mar 22.
3
Preeradication vaccine policy options for poliovirus infection and disease control.消灭前脊灰病毒感染和疾病控制的疫苗政策选择。
Risk Anal. 2013 Apr;33(4):516-43. doi: 10.1111/risa.12019. Epub 2013 Mar 5.
4
Expert review on poliovirus immunity and transmission.脊髓灰质炎病毒免疫与传播专家综述。
Risk Anal. 2013 Apr;33(4):544-605. doi: 10.1111/j.1539-6924.2012.01864.x. Epub 2012 Jul 15.
5
Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.当前全球消灭脊灰和控制政策选择:模型视角和停用口服脊灰疫苗的前提条件。
Expert Rev Vaccines. 2012 Apr;11(4):449-59. doi: 10.1586/erv.11.195.
6
Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response.美国脊髓灰质炎疫情风险和应对所需的脊灰疫苗供应的变化趋势。
Public Health Rep. 2012 Jan-Feb;127(1):23-37. doi: 10.1177/003335491212700104.
7
A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaks.用于预测和预防非洲野生脊髓灰质炎病毒国际传播的统计模型。
PLoS Med. 2011 Oct;8(10):e1001109. doi: 10.1371/journal.pmed.1001109. Epub 2011 Oct 18.
8
Strategic planning for measles control: using data to inform optimal vaccination strategies.麻疹控制的战略规划:利用数据制定最佳疫苗接种策略。
J Infect Dis. 2011 Jul;204 Suppl 1:S28-34. doi: 10.1093/infdis/jir095.
9
From emergence to eradication: the epidemiology of poliomyelitis deconstructed.从出现到消灭:脊髓灰质炎的流行病学剖析。
Am J Epidemiol. 2010 Dec 1;172(11):1213-29. doi: 10.1093/aje/kwq320. Epub 2010 Oct 26.
10
Implications of a circulating vaccine-derived poliovirus in Nigeria.尼日利亚循环疫苗衍生脊髓灰质炎病毒的影响。
N Engl J Med. 2010 Jun 24;362(25):2360-9. doi: 10.1056/NEJMoa0910074.